PostEra vs Isomorphic Labs

Side-by-side comparison of features, pricing, and ratings

Analysis reviewed Live tool data as of 2026-08-23
Cross-checked through our multi-step verification ·
Saved

At a glance

DimensionPostEraIsomorphic Labs
PricingContact for pricingContact for pricing
Lead Discovery ApproachActive learning with multi-property optimizationAlphaFold-based protein-ligand simulation
Key Partnership ScalePfizer ($610M), Amgen, $1B+ totalNovartis, Johnson & Johnson, $600M external round
Human-in-the-loopYes, medicinal chemists requiredYes, collaboration model
Best ForAccelerating Design-Make-Test cycleLarge-scale lead optimization with digital biology
Latest MilestoneNo recent newsSeries B (Feb 2026) + Johnson & Johnson deal (Jan 2026)

Choose PostEra if your team needs synthesis-aware medicinal chemistry with active learning and transparent partnership track record. Choose Isomorphic Labs if you are a large pharma seeking an AlphaFold-powered, simulation-first partner for ambitious discovery programs—but be prepared for a full collaboration model with higher barriers to entry.

PostEra
PostEra

AI-first medicinal chemistry platform for small molecule drug discovery

Visit Website
Isomorphic Labs
Isomorphic Labs

AI-first drug discovery partner built on Nobel-winning AlphaFold.

Visit Website
Pricing
Contact Sales
Contact Sales
Plans
Popularity
5 views
7.4k views
Skill Level
Advanced
Advanced
API Available
Platforms
Web
Categories
🧬 Drug Discovery & Life Sciences
🧬 Drug Discovery & Life Sciences
Features
Multi-property molecular optimization
AI-driven retrosynthetic analysis
Active learning for data-efficient experiments
Proprietary chemistry foundation models
Transparent AI with human-in-the-loop decision support
Accelerate design-make-test cycle
Collaborative platform for drug discovery partnerships
Synthesis-aware design
Built on Nobel-winning AlphaFold system
Generative AI molecule design via Drug Design Engine
Predictive AI models for protein-ligand interactions
Digital biology simulation at scale
End-to-end drug discovery from target ID to lead optimization
Partnership model with Novartis and Johnson & Johnson
Drug metabolism and toxicity simulation
Bioresilience framework for pandemic preparedness
US operations established in 2025
Series B funding in February 2026
Max Jaderberg appointed as President
Dr. Ben Wolf appointed as Chief Medical Officer
Interdisciplinary team of ML and drug discovery experts

What real users say: PostEra vs Isomorphic Labs

Not marketing copy and not our opinion — a structured sweep of public discussion (reviews, forums, communities and video comments), showing what people praise and what they complain about for each tool.

PostEra

4 mentions across 1 sources · 50% positive — mixed

Lemmy

What users praise

  • Transparent AI with publications and validated partnerships.
  • Proprietary chemistry foundation models for accurate predictions.
  • Active learning reduces experimental iterations and costs.
  • State-of-the-art retrosynthetic analysis suggests reliable synthesis routes.

What frustrates them

  • Complete lack of user reviews or community feedback.
  • Pricing is opaque, potentially excluding smaller organizations.
  • Highly specialized, with no utility outside medicinal chemistry.
  • No integration with common lab tools or platforms listed.

Researched Jul 3, 2026

Isomorphic Labs

48 mentions across 3 sources · 82% positive

Hacker News, YouTube, Lemmy

What users praise

  • Built on the Nobel-winning AlphaFold, giving it instant credibility in structural biology.
  • Drug Design Engine extends beyond structure to generative molecule design, promising novel chemistry.
  • Deep partnerships with Novartis and J&J, with potential billions in royalties.
  • Interdisciplinary team of top ML and drug discovery experts, ensuring depth of expertise.

What frustrates them

  • Not accessible to individual researchers or small biotech due to partnership model only.
  • Proprietary nature of parts of its tech limits community scrutiny and independent validation.
  • CASP16 results suggest AlphaFold 3-based models aren't always better than older methods for protein-ligand interactions.
  • No marketed drugs yet; outcomes remain uncertain with royalties tied to long timelines.

Researched Aug 18, 2026

Who should pick which

  • Large pharma innovation lab with established experimental capacity
    Pick: PostEra

    PostEra's Proton AI accelerates the Design-Make-Test cycle with retrosynthetic analysis and active learning, fitting well into existing workflows without requiring full platform overhaul.

  • Pharma company seeking long-term, large-scale drug development partnership
    Pick: Isomorphic Labs

    Isomorphic Labs' Drug Design Engine, built on AlphaFold, is ideal for massive lead optimization with digital biology, backed by $600M+ funding and partnerships with Novartis and Johnson & Johnson.

  • AI-driven drug discovery startup needing synthesis-aware design
    Pick: PostEra

    PostEra's transparent AI and active learning help startups gather informative experimental data efficiently, provided they have synthesis capabilities.

  • Research institution exploring digital biology frontiers
    Pick: Isomorphic Labs

    Isomorphic Labs' AlphaFold-based models are at the cutting edge of digital biology, though access requires a deep research collaboration.

Frequently Asked Questions

PostEra vs Isomorphic Labs: which should you choose?

Choose PostEra if your team needs synthesis-aware medicinal chemistry with active learning and transparent partnership track record. Choose Isomorphic Labs if you are a large pharma seeking an AlphaFold-powered, simulation-first partner for ambitious discovery programs—but be prepared for a full collaboration model with higher barriers to entry.

Do both tools require a partnership to use?

Yes, both PostEra and Isomorphic Labs operate on a partnership model with contact-based pricing, not as standalone software.

Which one is better for small molecule design?

PostEra is more specialized in medicinal chemistry with retrosynthesis and multi-property optimization, making it better suited for small molecule drug discovery.

Is AlphaFold available through Isomorphic Labs?

Isomorphic Labs builds on AlphaFold but uses proprietary models in its Drug Design Engine; AlphaFold itself is available separately through DeepMind.

Can I use PostEra without a chemistry team?

No, PostEra is designed for medicinal chemists and requires human-in-the-loop expertise.

What is the latest funding news for Isomorphic Labs?

Isomorphic Labs raised $600M in March 2025 and closed a Series B in February 2026.

Does PostEra have any recent announcements?

No recent news was captured for PostEra; the latest known milestone is the Pfizer partnership expansion in January 2025.

Which tool is more accessible for startups?

PostEra is more accessible as it integrates with existing synthesis workflows, while Isomorphic Labs requires large-scale pharma partnerships.

Are the AI models transparent in both tools?

PostEra emphasizes transparent AI with validated partnerships and publications; Isomorphic Labs does not detail transparency practices.

More PostEra or Isomorphic Labs comparisons

Explore each tool further

Browse these categories

Still deciding? Get the weekly AI tools brief

One email a week — new tools, honest comparisons, no spam.

Last reviewed: July 3, 2026